[DOI] [PubMed] [Google Scholar] 53.Fischer U.M., Cox C.S., Allen S.J., Stewart R.H., Mehlhorn U., Laine G.A
Immunogenicity: No Antibody Formation A critical safety consideration for any peptide therapy is immunogenicity, the potential to trigger immune system responses that could lead to allergic reactions, reduced efficacy through antibody neutralization, or autoimmune complications
Two of the most important are assisting with detoxification in the liver and its anti-inflammatory/immune function
American Association for Cancer Research Annual Proceedings 112(7):2886-2895, 2008
Due to the substrate specificity of different esterases, the enzymatic consideration should be systematically incorporated into the early design stage
Information Forms Available: Injections (intramuscular), sublingual tablets, oral tablets, capsules, chewables, gummies Key Ingredients: B1 (Thiamine), B2 (Riboflavin), B3 (Niacin), B5 (Pantothenic Acid), B6 (Pyridoxine), B7 (Biotin), B9 (Folic Acid), B12 (Methylcobalamin or Cyanocobalamin) Prescription Status: B12 injections require Rx in many countries
